Lazard (NYSE:LAZ) Stock, Quote.Headers.trade-ideas

Lazard

Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.

Kamala Harris happy

News

Politics

Here Are All The Wall Street Titans Backing Harris&#39;s Presidential Bid So Far

IBM Investment

Intraday Update

Markets

Movers

Trading Ideas

ASTS

BALY

BEAM

CBRE

COOP

JBHT

MORN

NDAQ

PEGA

PLXS

VKTX

VSAT

IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich &amp; Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday

Long Ideas

Media

PLTR

SRPT

ZBRA

Jim Cramer likes Enbridge Inc. (NYSE: ENB), says Lazard, Inc. (NYSE: LAZ) is a good buy, and Advanced Drainage Systems, Inc. (NYSE: WMS) is an incredible infrastructure play. He also mentions Jacobs Solutions Inc. (NYSE: J) and Sarepta Therapeutics, Inc. (NASDAQ: SRPT). Petrobras CEO was fired by Brazil&#39;s President, and Palantir Technologies Inc. (NYSE: PLTR) reported a 21% increase in first-quarter revenue.

Jim Cramer: This Industrial Stock Is Doing &#39;Very Well&#39;; Here&#39;s His Take On Palantir

Lazard Inc

Lazio Fan Token - United States Dollar

Luminar Technologies, Inc. - Class A Common Stock

Luminar Technologies Inc

Lazydays Holdings Inc Warrants (15/03/2023)

5 analysts have expressed a variety of opinions on Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $51.8, a high estimate of $56.00, and a low estimate of $42.00. Observing a 4.65% increase, the current average has risen from the previous average price target of $49.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1726153224_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Lazard is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$51.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Ramsden</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$42.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$58.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Lazard. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lazard compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Lazard's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Lazard's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LAZ/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Lazard analyst ratings.</a>
<h2>About Lazard</h2>
Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
<h3>Lazard: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Lazard's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 6.72%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Lazard's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 7.05%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lazard's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 11.52%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.08%, the company showcases effective utilization of assets.
Debt Management: Lazard's debt-to-equity ratio surpasses industry norms, standing at 5.18. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Analyst Ratings For Lazard

Wells Fargo analyst Michael Brown initiates coverage on Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Equal-Weight rating and announces Price Target of $51.

Price Target

Initiation

Wells Fargo Initiates Coverage On Lazard with Equal-Weight Rating, Announces Price Target of $51

Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported today that its preliminary assets under management ("AUM") as of July 31, 2024 totaled approximately $246.1 billion. The month's AUM included net outflows of $3.6 billion, market appreciation of $3.5 billion and foreign exchange appreciation of $1.5 billion.

Lazard Reported July 2024 Preliminary Assets Under Management Of $246.1B Vs $244.7B MoM

Key figures in the world of finance are rallying behind Vice President Kamala Harris in spite of her past tensions with Wall Street and her potential <a href="https://www.benzinga.com/news/24/07/39999337/survey-reveals-how-americans-feel-about-a-potential-female-president-and-what-it-means-for-kamala-ha">impact on financial sector stocks</a> if elected president.
What Happened: Billionaires such as Jonathan Gray of Blackstone, Marc Lasry from Avenue Capital Management, and philanthropist George Soros are among those endorsing Harris. 
Other high-profile supporters include media mogul Barry Diller and construction industry leader Bob Clark.
Key figures in finance, including Lazard&#8217;s CEO Peter Orszag, Evercore ISI&#8217;s co-founder Roger Altman, and Robert Rubin, ex-co-chairman of Goldman Sachs, are also reportedly backing Harris, Forbes <a href="https://www.forbes.com/sites/dereksaul/2024/07/27/kamala-harris-and-wall-street-heres-whos-backing-her-this-time-despite-fraught-history/">reports</a>.
Harris&#8217; stance on financial regulation is not extensively documented. But during her tenure as California&#8217;s attorney general, she negotiated a $20 billion settlement for homeowners with major banks over mismanagement of mortgages during the financial crisis.
Also Read: <a href="https://www.benzinga.com/news/24/07/39999519/trump-vs-harris-latest-survey-indicates-positive-signs-for-this-candidate">Trump Vs. Harris: Latest Survey Indicates Positive Signs For This Candidate</a>
According to the Forbes report, in her 2019 memoir, Harris compared a phone conversation with JPMorgan Chase CEO Jamie Dimon during those settlement talks to &#8220;two dogs in a fight.&#8221;
While a potential Harris administration&#8217;s policies towards banks remain uncertain, analysts predict that Donald Trump could be more beneficial to financial firms. Wall Street billionaires who are supporting Trump include former TD Ameritrade chairman J. Joe Ricketts, renowned investor John Paulson, and Stephen Schwarzman, who is Gray&#8217;s superior at Blackstone.
Why It Matters: The support for Harris from prominent Wall Street figures is intriguing given her past confrontations with the financial sector. Her pursuit of big banks during the mortgage crisis and her critical comments about industry leaders suggest a potentially tougher regulatory stance.
However, her backers may be betting on her ability to balance regulation with economic growth. The support from Wall Street could also indicate a desire for stability and predictability in policy-making, which could be beneficial for financial markets.
Read Next
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39999129/experts-weigh-in-on-harriss-fast-track-campaign-strategy-following-bidens-exit-i-think-shes-done-a-v">Experts Weigh In on Harris&#8217;s Fast-Track Campaign Strategy Following Biden&#8217;s Exit: &#8216;I Think She&#8217;s Done A Very Good Job&#8217;</a></li>
</ul>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Shutterstock

Here Are All The Wall Street Titans Backing Harris's Presidential Bid So Far

In the last three months, 4 analysts have published ratings on Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $52.0, a high estimate of $56.00, and a low estimate of $42.00. This current average has increased by 5.05% from the previous average price target of $49.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1722013272_0_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of Lazard by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Ramsden</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$42.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$58.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Lazard. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lazard compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Lazard's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LAZ/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Lazard analyst ratings.</a>
<h2>All You Need to Know About Lazard</h2>
Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
<h3>Lazard: Delving into Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Lazard's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately 40.91%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 4.45%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Lazard's ROE stands out, surpassing industry averages. With an impressive ROE of 8.45%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.75%, the company showcases effective utilization of assets.
Debt Management: Lazard's debt-to-equity ratio is notably higher than the industry average. With a ratio of 5.9, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Lazard Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Goldman Sachs analyst Richard Ramsden maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Sell and raises the price target from $38 to $42.

Goldman Sachs Maintains Sell on Lazard, Raises Price Target to $42

Keefe, Bruyette &amp; Woods analyst Aidan Hall reiterates Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Outperform and raises the price target from $49 to $56.

Reiteration

Keefe, Bruyette & Woods Reiterates Outperform on Lazard, Raises Price Target to $56

WIIM

Lazard shares are trading higher following better-than-expected Q2 earnings.

U.S. stocks were higher, with the Dow Jones index gaining more than 1% on Thursday.
Shares of International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) rose during Thursday's session following strong <a href="https://www.benzinga.com/news/24/07/39961144/why-ibm-stock-is-trading-higher-on-thursday">quarterly earnings</a>.
IBM reported quarterly earnings of $2.43 per share, which beat the analyst consensus estimate of $2.19. Quarterly sales clocked in at $15.8 billion, which beat the analyst consensus estimate of $15.616 billion.
IBM shares gained 6.4% to $195.75 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) shares surged 28.2% to $64.64 after the company reported better-than-expected second-quarter EPS results.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) jumped 25.2% to $16.72. The company announced the successful completion of its first five commercial satellites.</li>
<li>Bally&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) shares rose 24.2% to $16.80. Bally&#8217;s entered into merger agreement with affiliates of Standard General L.P.</li>
<li>Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) gained 18.3% to $341.39 following better-than-expected quarterly earnings.</li>
<li>Carpenter Technology Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) jumped 16.3% to $141.59 after the company reported better-than-expected quarterly financial results.</li>
<li>RPC, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RES#NYSE">RES</a>) rose 15.1% to $6.64 following upbeat earnings.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) rose 13.7% to $831.97 after the company reported better-than-expected second-quarter financial results.</li>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) jumped 13.6% to $19.05.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) gained 13.1% to $69.09 after the company reported better-than-expected second-quarter financial results.</li>
<li>Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) gained 12.5% to $42.46 following third-quarter results.</li>
<li>CBRE Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) surged 11.7% to $109.87 after the company raised its 2024 guidance.</li>
<li>Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) climbed 11.1% to $300.96 following upbeat earnings.</li>
<li>Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) rose 11% to $48.08 following better-than-expected quarterly earnings.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) rose 10.7% to $571.01 after the company reported better-than-expected quarterly adjusted EPS and sales.</li>
<li>Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) gained 10.5% to $128.36 following upbeat earnings.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) surged 10.2% to $5.80.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) rose 10.1% to $32.81.</li>
<li>Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) gained 10.1% to $53.92 following second-quarter results.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) shares climbed 9.6% to $565.64 after the company reported better-than-expected second-quarter adjusted EPS and sales.</li>
<li>Mr. Cooper Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NYSE">COOP</a>) gained 9.5% to $94.86 following second-quarter results.</li>
<li>RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) climbed 9.2% to $121.14 after the company reported better-than-expected quarterly earnings.</li>
<li>Oceaneering International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) rose 9.2% to $27.79 following strong sales.</li>
<li>Masco Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) gained 8.1% to $76.27 after the company reported better-than-expected second-quarter earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) rose 8.1% to $201.00 after the company reported better-than-expected second-quarter earnings and increased FY 2024 guidance.</li>
<li>RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) climbed 8% to $113.24 following a second-quarter earnings beat.</li>
<li>Morningstar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORN#NASDAQ">MORN</a>) rose 7.8% to $328.71. The company reported second-quarter financial results yesterday.</li>
<li>Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) gained 7.4% to $67.36 after the company reported better-than-expected second-quarter financial results.</li>
<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) rose 7.4% to $262.60.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) shares rose 6.1% to $173.75.</li>
<li>Unilever PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>) gained 5.9% to $59.90 following HI results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39961795/apple-to-rally-around-10-here-are-10-top-analyst-forecasts-for-thursday">Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday</a></li>
</ul>

IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday

Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.35 by 48.57 percent. The company reported quarterly sales of $684.642 million which beat the analyst consensus estimate of $638.743 million by 7.19 percent. This is a 10.42 percent increase over sales of $620.026 million the same period last year.

Earnings

Earnings Beats

Lazard Q2 2024 Adj EPS $0.52 Beats $0.35 Estimate, Sales $684.642M Beat $638.743M Estimate

Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Overweight and raises the price target from $53 to $56.

Morgan Stanley Maintains Overweight on Lazard, Raises Price Target to $56

Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported today that its preliminary assets under management (&quot;AUM&quot;) as of June 30, 2024 totaled approximately&nbsp;$244.7 billion. The month&#39;s AUM included market appreciation of&nbsp;$2.5 billion, net outflows of&nbsp;$1.4 billion&nbsp;and foreign exchange depreciation of&nbsp;$1.4 billion. Preliminary average AUM for the quarter ended June 30, 2024 was&nbsp;$245.3 billion.

Lazard Reports June 2024 Assets Under Management Of $244.7B, Preliminary Average AUM Of $245.3B For The Quarter

Shares of investment banks are trading higher. The financial sector may be reacting to Thursday's presidential debate.

In the preceding three months, 4 analysts have released ratings for Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $51.25, along with a high estimate of $58.00 and a low estimate of $44.00. This upward trend is apparent, with the current average reflecting a 1.14% increase from the previous average price target of $50.67.
<img src="https://www.benzinga.com/files/images/story/2024/1718985685_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Lazard. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$49.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$58.00</td>
<td>-</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$43.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Lazard. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Lazard compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Lazard's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Lazard's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LAZ/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Lazard analyst ratings.</a>
<h2>About Lazard</h2>
Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
<h3>A Deep Dive into Lazard's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Lazard displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 40.91%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Lazard's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 4.45%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lazard's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.45% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Lazard's ROA stands out, surpassing industry averages. With an impressive ROA of 0.75%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Lazard's debt-to-equity ratio surpasses industry norms, standing at 5.9. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Lazard In The Eyes Of 4 Experts

Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Overweight and lowers the price target from $58 to $54.

Morgan Stanley Maintains Overweight on Lazard, Lowers Price Target to $54

Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported today that its preliminary assets under management (&quot;AUM&quot;) as of May 31, 2024 totaled approximately&nbsp;$245.0 billion. The month&#39;s AUM included market appreciation of&nbsp;$4.4 billion, net outflows of&nbsp;$1.6 billion&nbsp;and foreign exchange appreciation of&nbsp;$1.4 billion.
<table cellspacing="0">
<tbody>
<tr>
<td colspan="4" rowspan="1">
LAZARD, INC.
ASSETS UNDER MANAGEMENT (&quot;AUM&quot;)
(unaudited)
($ in millions)
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="2" rowspan="1">
As of:
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
May 31,
</td>
<td colspan="1" rowspan="1">
April 30,
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
20241
</td>
<td colspan="1" rowspan="1">
2024
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Equity
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
$190,820
</td>
<td colspan="1" rowspan="1">
$187,582
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Fixed Income
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
46,362
</td>
<td colspan="1" rowspan="1">
45,399
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Other
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
7,826
</td>
<td colspan="1" rowspan="1">
7,824
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Total AUM
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
$245,008
</td>
<td colspan="1" rowspan="1">
$240,805
</td>
</tr>
</tbody>
</table>

Lazard Reports May 2024 Assets Under Management of $245.0B, Vs $240.8B In April 2024

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said he likes Enbridge Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENB#NYSE">ENB</a>). &#8220;I trust that management <a href="https://www.benzinga.com/quote/ENB/analyst-ratings">team,&#8221; he added</a>.
On May 10, Enbridge posted better-than-expected quarterly earnings.
Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) is a good buy here, Cramer said. &#8220;I do believe that things are going to get a little less onerous&#8230; when it comes to takeovers.&#8221;
On May 20, Lazard announced that Ben Braun joined the firm as managing director and global head of Media, Entertainment &amp; Sports Advisory.
Cramer recommended staying away from AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) as there are so many great companies. &#8220;We don't need to be in that one,&#8221; he added.
On May 15, AST SpaceMobile and AT&amp;T announced a definitive commercial agreement.
The &#8220;Mad Money&#8221; host said Advanced Drainage Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMS#NYSE">WMS</a>) is &#8220;another incredible infrastructure play.&#8221;
On May 16, Advanced Drainage Systems posted upbeat quarterly sales.
Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) has &#8220;made it all the way back. Halleluiah for them,&#8221; Cramer said.
On May 20, Zebra Technologies announced the launch of a $500 million senior unsecured note private offering.
Jacobs Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) is doing &#8220;very well,&#8221; Cramer said. &#8220;I would want to own it.&#8221;
Last week, Jacobs announced the appointment of Venk Nathamuni as the company&#8217;s new chief financial officer, effective June 3.
&#8220;Let's stick with domestic,&#8221; Cramer said when asked about Petróleo Brasileiro S.A. &#8211; Petrobras (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>).
Last week, Brazil President Luiz Inacio Lula da Silva fired Petrobras CEO following a dispute over dividend payments.
Cramer said he is not going to say no to Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>). &#8220;It has been a company that has not made money but is about to break out and make money,&#8221; he noted.
On May 1, Sarepta Therapeutics reported better-than-expected first-quarter financial results.
Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) is fine, Cramer said. &#8220;It's got good commercial and good military.&#8221;
On May 6, Palantir said first-quarter revenue increased 21% year-over-year to $634 million, which beat the consensus estimate of $625.431 million.
Price Action:
<ul>
<li>Lazard shares gained 0.4% to settle at $41.16 on Tuesday.</li>
<li>Enbridge shares closed at $36.78 on Tuesday.</li>
<li>Petroleo Brasileiro shares slipped 0.7% to settle at $15.02.</li>
<li>Advanced Drainage System shares gained 1.1% to settle at $179.24 on Tuesday.</li>
<li>AST SpaceMobile shares fell 10.8% to settle at $4.71.</li>
<li>Zebra Technologies shares gained 0.5% to close at $321.78 on Tuesday.</li>
<li>Palantir shares fell 1.8% to close at $21.24.</li>
<li>Sarepta Therapeutics shares fell 1.3% to settle at $129.12.</li>
<li>Shares of Jacobs Solutions gained 1.4% to close at $ 138.79 during Tuesday's session.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38939401/top-5-health-care-stocks-which-could-rescue-your-portfolio-this-month">Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month</a>
Photo: Shutterstock

Jim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On Palantir

Keefe, Bruyette &amp; Woods analyst Aidan Hall reiterates Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Outperform and lowers the price target from $51 to $49.

Keefe, Bruyette & Woods Reiterates Outperform on Lazard, Lowers Price Target to $49

Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.51 by 29.41 percent. The company reported quarterly sales of $765.00 million which beat the analyst consensus estimate of $668.12 million by 14.50 percent. This is a 45.16 percent increase over sales of $527.02 million the same period last year.

Lazard Q1 2024 Adj EPS $0.66 Beats $0.51 Estimate, Sales $765.00M Beat $668.12M Estimate

Lazard, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) said on Thursday that it had inked a pact with an established&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/b38306545/lazard-and-elaia-partners-form-strategic-partnership-including-the-launch-of-lazard-elaia-capital-" rel="noreferrer noopener">European venture capital firm, Elaia Partners.</a>
The company plans to create a leading European player focused on investment in technology companies, supporting them at all stages of their development, from seed to listing on public markets.&nbsp;
The partnership involves the creation of a new Paris-based asset management company, Lazard Elaia Capital (LEC), which will be 75%-owned by Lazard and 25%-owned by Elaia Partners.&nbsp;
This investment platform targets the capital requirements of upcoming technology and deep tech leaders in late-stage and growth equity.&nbsp;
An inaugural fund focusing on Europe is slated for launch by 2025, pending regulatory clearance.
As part of this strategic partnership, Lazard has acquired a minority stake in Elaia Partners. The agreement provides the option for Lazard to purchase up to 100% ownership over time.
&#8220;The creation of this partnership between Lazard and Elaia Partners will enable us to offer our clients innovative, private market solutions focusing on the growing technology industry in Europe,&#8221; said Evan Russo, Chief Executive Officer, Lazard Asset Management.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, LAZ stock has gained over 9% in the past year. Investors can gain exposure to the stock via ETF Opportunities Trust Cultivar ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/CVAR#BATS">CVAR</a>).
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38270560/joby-aviation-may-launch-flying-taxis-by-2025-whats-going-on" rel="noreferrer noopener">Joby Aviation May Launch Flying Taxis By 2025 &#8211; What&#8217;s Going On?</a>
Price Action: LAZ shares traded higher by 0.93% to $37.79 on Thursday.
Photo via Shutterstock

Equities

General

CVAR

Lazard Partners With Elaia To Launch European Tech Investment Powerhouse

Lazard reports July AUM of $246.1B

Lazard (LAZ – Research Report), the Financial sector company, was revisited by a Wall Street analyst today. Analyst Ryan Kenny from Morgan Stanley ...

Buy Rating Affirmed: Lazard's Asset Growth Defies Outflows and Market Challenges

In a report released yesterday, Aidan Hall from KBW maintained a Buy rating on Lazard (LAZ – Research Report), with a price target of $56.00. The c...

Lazard (LAZ) Receives a Buy from KBW

Seaport Global analyst James Mitchell maintained a Buy rating on Lazard (LAZ – Research Report) today and set a price target of $55.00. The company...

Seaport Global Reaffirms Their Buy Rating on Lazard (LAZ)

UBS updates its 'election watch' stocks to match new winning probabilities

Tracking John Rogers' Ariel Investments Portfolio - Q2 2024 Update

Lazard reports dip in August AUM amid net outflows

There's a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on US Bancorp (USB – Research Report), Mastercard (MA – ...

Analysts Are Bullish on These Financial Stocks: US Bancorp (USB), Mastercard (MA)

In a report released today, Ryan Kenny from Morgan Stanley maintained a Buy rating on Lazard (LAZ – Research Report), with a price target of $56.00...

Morgan Stanley Sticks to Their Buy Rating for Lazard (LAZ)

How financial stocks may fare in a 'game of regulatory seats' under a Trump White House

AMAT

APTV

ARCC

ATGE

BAIDF

BIDU

BOKF

BXSL

CHKP

COIN

EWBC

FMCC

FNMA

FSLR

GILD

GNRC

GNTX

HOOD

INTC

KLAC

MGRB

MGRD

MGRE

MSFT

MSGE

NTRS

NTRSO

OBDC

PARA

PARAA

PYPL

REZI

SAEF

SPHR

STLD

TSCO

TSLA

ZION

Press Releases

Lazard Global Total Return and Income Fund Announces Increased Monthly Distribution

Lazard to Announce Second Quarter and First-Half 2024 Financial Results

Lazard Reports June 2024 Assets Under Management

Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in June

Lazard Declares Quarterly Dividend of $0.50 Per Share

Lazard Reports Second-Quarter and First-Half 2024 Results

Lazard Reports July 2024 Assets Under Management

Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in July

Robert Forsyth Joins Lazard Asset Management as Global Head of ETFs

Lazard Reports August 2024 Assets Under Management

BGC Group

Evercore

Freedom Holding

Futu Holdings Limited - American Depositary Shares

Futu Hldgs

Goldman Sachs Group, Inc. (The) Common Stock

Goldman Sachs Gr

Houlihan Lokey, Inc. Class A Common Stock

Houlihan Lokey

Robinhood Markets, Inc. - Class A Common Stock

Robinhood Markets

Interactive Brokers Group, Inc. - Class A Common Stock

Interactive Brokers Gr

Jefferies Financial Group Inc. Common Stock

Jefferies Financial Gr

LPL Financial Holdings Inc. - Common Stock

LPL Finl Hldgs

Moelis

Marex Group

Morgan Stanley

Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings

Oppenheimer Holdings, Inc. Class A Common Stock (DE)

Oppenheimer Hldgs

Piper Sandler

PJT Partners

Perella Weinberg Partners - Class A Common Stock

Perella Weinberg

Raymond James Financial, Inc. Common Stock

Raymond James Finl

Charles Schwab Corporation (The) Common Stock

Charles Schwab

Stifel Financial Corporation Common Stock

Stifel Financial

StoneX Group

UP Fintech Holding Limited - American Depositary Shares representing fifteen Class A Ordinary Shares

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Lazard

Lazard (LAZ) Forecast

Lazard (NYSE:LAZ) Stock, Quote.Headers.trade-ideas